The human-microbiome superorganism and its modulation to restore health

被引:88
作者
Salvucci, E. [1 ,2 ,3 ]
机构
[1] UNC, CONICET, ICYTAC, Cordoba, Argentina
[2] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Cordoba, Argentina
[3] Univ Nacl Cordoba, Fac Ciencias Agr, Cordoba, Argentina
关键词
Microbiome; prebiotics; probiotics; neurodevelopmental disorders; Bifidobacterium; microbiome-brain axis; CHAIN FATTY-ACIDS; TRICHURIS-SUIS THERAPY; GUT MICROBIOME; ARABINOXYLAN-OLIGOSACCHARIDES; TRANSPOSABLE ELEMENTS; NEUROTROPHIC FACTOR; ALLERGIC DISEASE; RETT-SYNDROME; DOUBLE-BLIND; BDNF LEVELS;
D O I
10.1080/09637486.2019.1580682
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Microbiome is the community of microorganism that co-live with a host. The human being is the result of the integration of its genome and the coexistence with millions of microorganisms throughout its evolutionary history. Human-microbiome association can be considered a step of integration in evolution, constituting a superorganism. Many emergent diseases are related to the loss of part of this microbiome and its restoration can be achieved by different strategies. Gut microbiome imbalance is particularly associated with numerous inflammatory, immune and nervous system-related diseases by a communication pathway called microbiome-brain axis. Modulation of microbiome by administering prebiotics, like arabinoxylans, and synbiotics is a plausible treatment for dysbiosis, the regulation of neurotransmitters and alleviation of neurological manifestations.
引用
收藏
页码:781 / 795
页数:15
相关论文
共 151 条
[1]   Symbiogenesis: Beyond the endosymbiosis theory? [J].
Aanen, Duur K. ;
Eggleton, Paul .
JOURNAL OF THEORETICAL BIOLOGY, 2017, 434 :99-103
[2]   Probiotics and their Effects on Metabolic Diseases: An Update [J].
Aggarwal, Juhi ;
Swami, Gaurav ;
Kumar, Mayur .
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2013, 7 (01) :173-177
[3]   Bifidobacterium pseudocatenulatum CECT 7765 Ameliorates Neuroendocrine Alterations Associated with an Exaggerated Stress Response and Anhedonia in Obese Mice [J].
Agusti, Ana ;
Moya-Perez, A. ;
Campillo, I. ;
Montserrat-de la Paz, S. ;
Cerrudo, V. ;
Perez-Villalba, A. ;
Sanz, Yolanda .
MOLECULAR NEUROBIOLOGY, 2018, 55 (06) :5337-5352
[4]   Prebiotics as functional foods: A review [J].
Al-Sheraji, Sadeq Hasan ;
Ismail, Amin ;
Manap, Mohd Yazid ;
Mustafa, Shuhaimi ;
Yusof, Rokiah Mohd ;
Hassan, Fouad Abdulrahman .
JOURNAL OF FUNCTIONAL FOODS, 2013, 5 (04) :1542-1553
[5]   GDNF, NGF and BDNF as therapeutic options for neurodegeneration [J].
Allen, Shelley J. ;
Watson, Judy J. ;
Shoemark, Deborah K. ;
Barua, Neil U. ;
Patel, Nikunj K. .
PHARMACOLOGY & THERAPEUTICS, 2013, 138 (02) :155-175
[6]   The intestinal microbiome in early life: health and disease [J].
Arrieta, Marie-Claire ;
Stiemsma, Leah T. ;
Amenyogbe, Nelly ;
Brown, Eric M. ;
Finlay, Brett .
FRONTIERS IN IMMUNOLOGY, 2014, 5
[7]   Probiotics modulate gut microbiota and improve insulin sensitivity in DIO mice [J].
Bagarolli, Renata A. ;
Tobar, Natalia ;
Oliveira, Alexandre G. ;
Araujo, Tiago G. ;
Carvalho, Bruno M. ;
Rocha, Guilherme Z. ;
Vecina, Juliana F. ;
Calisto, Kelly ;
Guadagnini, Dioze ;
Prada, Patricia O. ;
Santos, Andrey ;
Saad, Sara T. O. ;
Saad, Mario J. A. .
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2017, 50 :16-25
[8]   Trichuris suis ova therapy for allergic rhinitis: A randomized, double-blind, placebo-controlled clinical trial [J].
Bager, Peter ;
Arnved, John ;
Ronborg, Steen ;
Wohlfahrt, Jan ;
Poulsen, Lars K. ;
Westergaard, Tine ;
Petersen, Henning Willads ;
Kristensen, Bjarne ;
Thamsborg, Stig ;
Roepstorff, Allan ;
Kapel, Christian ;
Melbye, Mads .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (01) :123-130
[9]  
Bak SH, 2017, INTEST RES, V15, P244, DOI 10.5217/ir.2017.15.2.244
[10]   Implications of the human microbiome in inflammatory bowel diseases [J].
Bakhtiar, Syeda M. ;
Guy LeBlanc, Jean ;
Salvucci, Emiliano ;
Ali, Amjad ;
Martin, Rebeca ;
Langella, Philippe ;
Chatel, Jean-Marc ;
Miyoshi, Anderson ;
Bermudez-Humaran, Luis G. ;
Azevedo, Vasco .
FEMS MICROBIOLOGY LETTERS, 2013, 342 (01) :10-17